Welcome to our dedicated page for Figs news (Ticker: FIGS), a resource for investors and traders seeking the latest updates and insights on Figs stock.
FIGS Inc (FIGS) delivers innovative medical apparel through advanced fabric technology and a vertically integrated digital platform. This resource provides investors and healthcare professionals with centralized access to official company announcements and verified news developments.
Track FIGS' strategic initiatives including technical textile advancements, e-commerce platform enhancements, and healthcare sector partnerships. Our aggregation includes earnings disclosures, product line expansions, and operational updates directly affecting the medical apparel market.
Key focus areas mirror FIGS' corporate priorities: antimicrobial fabric research, direct-to-consumer sales metrics, and sustainable manufacturing processes. Users receive timely updates on scrubs market positioning and digital retail innovations without promotional bias.
Bookmark this page for efficient monitoring of FIGS' market movements, including regulatory filings and leadership changes. Combine quarterly financial results with product innovation timelines for comprehensive analysis of this healthcare apparel innovator.
FIGS, Inc. (NYSE: FIGS), a healthcare apparel brand, announced participation in a fireside chat at the Goldman Sachs 29th Annual Global Retailing Conference. The chat will feature CEO Trina Spear and CFO Daniella Turenshine on Thursday, September 8, 2022, at 1:45 p.m. ET. Investors can access the live webcast through FIGS' investor relations page, with a recording available for 90 days post-event. FIGS specializes in creating advanced, comfortable, and stylish apparel for healthcare professionals, marketed directly through its digital platform.
FIGS, Inc. announced a 20.9% year-over-year growth in net revenues, reaching $122.2 million in Q2 2022. The company achieved a net income of $4.9 million and an Adjusted EBITDA margin of 17.6%, although this was a decline from the previous year. Operating expenses decreased by 27.6% to $76.9 million. The company maintained its revenue outlook of $510 to $530 million for the year. Leadership changes were announced, with Trina Spear becoming the sole CEO and Heather Hasson assuming the role of Executive Chair.
FIGS, Inc. (NYSE: FIGS) will release its second quarter 2022 financial results on August 4, 2022, after U.S. markets close. A conference call to discuss results will follow at 2:00 p.m. PT / 5:00 p.m. ET. Shareholders can submit questions via Say Technologies starting July 28 until 24 hours before the call. The session will include a Q&A segment with management. For more details, visit ir.wearfigs.com.
FIGS, Inc. reported Q1 2022 net revenues of $110.1 million, up 26.4% year-over-year. Despite strong sales, gross margin decreased to 71.2% due to high freight costs. Operating expenses surged 39.7% to $64.7 million, raising the operating expense ratio to 58.8%. Net income reached $8.9 million with diluted EPS of $0.05. The company revised its full-year revenue outlook to $510-$530 million, down from $550-$560 million, attributing this to supply chain challenges and inflation. Adjusted EBITDA margin is now expected between 16% and 18%.
On May 6, 2022, Crocs (NASDAQ: CROX) announced the return of its Free Pair for Healthcare program alongside FIGS (NYSE: FIGS). To honor healthcare workers during National Nurses Week, the initiative will distribute 10,000 pairs of Crocs shoes and 10,000 FIGS scrubs. Since March 2020, Crocs has donated nearly 1 million pairs of shoes to healthcare professionals globally. Eligible healthcare workers can enter the drawing until May 12, 2022, for a chance to win these items. The initiative underscores Crocs' commitment to comfort and support for healthcare heroes.
FIGS, Inc. (NYSE: FIGS) will announce its first quarter 2022 financial results on May 12, 2022, after U.S. markets close. Following the release, management will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss results and outlook. A financial highlights presentation will be available on the investor relations website prior to the call. Shareholders can submit questions via a new Q&A platform starting May 2, 2022. Recorded replays of the call will be accessible for one week after the live event.
FIGS, Inc. (NYSE: FIGS) has established a Healthcare Advisory Board comprised of seven distinguished healthcare professionals. This initiative aims to enhance the company's engagement with the healthcare community, impacting product development, messaging, and community-building efforts. Co-CEOs Heather Hasson and Trina Spear emphasized the commitment to understanding healthcare professionals' needs for a transformative approach. The board includes experts from various fields, promising to bolster FIGS' mission to support and elevate the healthcare profession.
FIGS, Inc. (NYSE: FIGS) has appointed three new independent directors to its Board of Directors, effective April 1, 2022. A.G. Lafley, Ken Lin, and Jeffrey Wilke bring extensive experience in public company leadership, technology, and operations. Lafley previously served as CEO of Procter & Gamble, Lin is the founder of Credit Karma, and Wilke held key leadership roles at Amazon. Co-CEO Heather Hasson expressed confidence in their ability to help FIGS capitalize on growth opportunities in the healthcare apparel market.
FIGS, Inc. reported a record net revenue of $420 million for 2021, marking a 60% increase year-over-year. In Q4 2021, the company achieved net revenues of $128.7 million, up 42.7%. However, the gross margin decreased to 69.9%. The net income for the full year was a loss of $9.6 million, impacted by stock-based compensation related to its IPO. Active customers grew by 46% to 1.9 million, with an outlook for 2022 net revenues between $550-$560 million.
